These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Extraction of amino acids by reverse iontophoresis: simulation of therapeutic monitoring in vitro. Sieg A; Jeanneret F; Fathi M; Hochstrasser D; Rudaz S; Veuthey JL; Guy RH; Delgado-Charro MB Eur J Pharm Biopharm; 2008 Nov; 70(3):908-13. PubMed ID: 18675906 [TBL] [Abstract][Full Text] [Related]
7. Reverse iontophoretic monitoring in premature neonates: feasibility and potential. Sekkat N; Naik A; Kalia YN; Glikfeld P; Guy RH J Control Release; 2002 May; 81(1-2):83-9. PubMed ID: 11992681 [TBL] [Abstract][Full Text] [Related]
8. Reverse iontophoresis as a noninvasive tool for lithium monitoring and pharmacokinetic profiling. Leboulanger B; Fathi M; Guy RH; Delgado-Charro MB Pharm Res; 2004 Jul; 21(7):1214-22. PubMed ID: 15290862 [TBL] [Abstract][Full Text] [Related]
9. Non-invasive monitoring of phenytoin by reverse iontophoresis. Leboulanger B; Guy RH; Delgado-Charro MB Eur J Pharm Sci; 2004 Aug; 22(5):427-33. PubMed ID: 15265512 [TBL] [Abstract][Full Text] [Related]
10. Modelling formation of a drug reservoir in the stratum corneum and its impact on drug monitoring using reverse iontophoresis. Paulley Y; Delgado-Charro MB; White KA Comput Math Methods Med; 2010 Dec; 11(4):353-68. PubMed ID: 21058079 [TBL] [Abstract][Full Text] [Related]
11. Electrically-assisted delivery of an anionic protein across intact skin: cathodal iontophoresis of biologically active ribonuclease T1. Dubey S; Kalia YN J Control Release; 2011 Jun; 152(3):356-62. PubMed ID: 21397646 [TBL] [Abstract][Full Text] [Related]
12. Noninvasive glucose monitoring by reverse iontophoresis in vivo: application of the internal standard concept. Sieg A; Guy RH; Delgado-Charro MB Clin Chem; 2004 Aug; 50(8):1383-90. PubMed ID: 15155544 [TBL] [Abstract][Full Text] [Related]
13. Transdermal reverse iontophoresis of valproate: a noninvasive method for therapeutic drug monitoring. Delgado-Charro MB; Guy RH Pharm Res; 2003 Sep; 20(9):1508-13. PubMed ID: 14567648 [TBL] [Abstract][Full Text] [Related]
15. Mathematical models to describe iontophoretic transport in vitro and in vivo and the effect of current application on the skin barrier. Gratieri T; Kalia YN Adv Drug Deliv Rev; 2013 Feb; 65(2):315-29. PubMed ID: 22626977 [TBL] [Abstract][Full Text] [Related]
16. Reverse Iontophoretic Extraction of Gabapentin: A Mechanistic Study. Chakrabarty S; Ghosh B; Giri TK; Khanam J Curr Drug Deliv; 2018; 15(7):965-971. PubMed ID: 29732968 [TBL] [Abstract][Full Text] [Related]
17. Diagnostic and therapeutic applications of iontophoresis. Sieg A; Wascotte V J Drug Target; 2009 Nov; 17(9):690-700. PubMed ID: 19845485 [TBL] [Abstract][Full Text] [Related]
18. Reverse iontophoresis with the development of flexible electronics: A review. Zheng H; Pu Z; Wu H; Li C; Zhang X; Li D Biosens Bioelectron; 2023 Mar; 223():115036. PubMed ID: 36580817 [TBL] [Abstract][Full Text] [Related]
19. Cortisol extraction through human skin by reverse iontophoresis. Ventura SA; Heikenfeld J; Brooks T; Esfandiari L; Boyce S; Park Y; Kasting GB Bioelectrochemistry; 2017 Apr; 114():54-60. PubMed ID: 28081473 [TBL] [Abstract][Full Text] [Related]
20. Controlled iontophoretic transport of huperzine A across skin in vitro and in vivo: effect of delivery conditions and comparison of pharmacokinetic models. Kalaria DR; Patel P; Merino V; Patravale VB; Kalia YN Mol Pharm; 2013 Nov; 10(11):4322-9. PubMed ID: 24028565 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]